BODALCHEM.BO(BODALCHEM.BO)
BODALCHEM.BO
No analyst ratings available
No analyst price targets available for BODALCHEM.BO
Analyst coverage may not be available for this symbol
Earnings surprise history unavailable.
No recent analyst actions
| Metric | FY2027E |
|---|---|
| Revenue Avg | $22.23B |
| Low | $22.23B |
| High | $22.23B |
| EBITDA Avg | $2.07B |
| Low | $2.07B |
| High | $2.07B |
| EBIT Avg | $1.30B |
| Low | $1.30B |
| High | $1.30B |
| Net Income Avg | $894M |
| Low | $894M |
| High | $894M |
| EPS Avg | $7.10 |
| Low | $7.10 |
| High | $7.10 |
| Analysts (Rev / EPS) | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q4 2028 | Q1 2029 | Q2 2029 | Q3 2029 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $4.25B | $4.42B | $4.82B | $4.93B | $3.98B | $4.45B | $4.50B | $4.15B |
| Low | $4.25B | $4.42B | $4.82B | $4.93B | $3.98B | $4.45B | $4.50B | $4.15B |
| High | $4.25B | $4.42B | $4.82B | $4.93B | $3.98B | $4.45B | $4.50B | $4.15B |
| EBITDA Avg | $396M | $411M | $449M | $460M | $371M | $414M | $419M | $387M |
| Low | $396M | $411M | $449M | $460M | $371M | $414M | $419M | $387M |
| High | $396M | $411M | $449M | $460M | $371M | $414M | $419M | $387M |
| EBIT Avg | $248M | $257M | $281M | $288M | $232M | $259M | $262M | $242M |
| Low | $248M | $257M | $281M | $288M | $232M | $259M | $262M | $242M |
| High | $248M | $257M | $281M | $288M | $232M | $259M | $262M | $242M |
| Net Income Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| EPS Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — |